Skip to main content






The AACE 27th Annual Scientific and Clinical Congress is structured to provide relevant clinical information for the practicing endocrinologist. The program will focus on information that will allow you to achieve the best solutions for the diagnosis and management of endocrine diseases.

What is Eligible for Submission?

  • Abstracts may be submitted by AACE members or non-members sponsored by an AACE Member. If you are not a member, you may join online at
  • Abstracts describing original research, clinical trials, or case studies/series related to the area of endocrinology may be submitted.
  • Abstract submissions must be an original contribution and may not have previously been presented at any national U.S. meeting(s) (or published as a result of such a meeting) in the same format.
  • By submitting your abstract, you agree to present the abstract if it is selected for presentation during a poster presentation at the Annual Meeting in Boston, MA.
  • All accepted abstracts will be published as a supplement to Endocrine Practice.
  • If the abstract reports results of a clinical trial not yet approved by a regulatory agency, you will be required to identify the trial phase.
  • Please note that oral presentations will be submitted as a part of the Annual Meeting 2018 CME application for CME credit. For this reason, abstract authors selected for oral presentations will be required to submit standard CME forms to AACE, including attestations regarding content validation, content & format without commercial bias, and other reminders for speakers; disclosures of relevant financial relationship; objectives; and guidelines for presentation and syllabus materials. Speakers selected for oral presentation should not be employees of a commercial interest. The primary/submitting author on the abstract is not required to be the presenter if selected for oral presentation.

What is Not Eligible for Submission?

  • The same study should not be submitted as multiple abstracts. Abstracts that appear as more than one version of a single study will be rejected.
  • Abstracts submitted for the late-breaking category cannot be submitted to another category.
  • Submitting authors who are not AACE members or do not have an AACE member sponsor will not be eligible to submit.
  • Abstracts that have been previously presented at any national US meeting or published as a result of the meeting.

Abstract Categories

  • Adrenal Disorders, Diabetes Mellitus/Prediabetes, Hypoglycemia, Lipid/Cardiovascular Disorders/ Hypertension, Metabolic Bone Disease, Obesity, Pituitary Disorders/Neuroendocrinology, Reproductive Endocrinology, Thyroid Disease, and Other.

Abstract Title Format

  • Titles should be brief, clearly indicating the nature of the presentation.
  • Trial group names should not appear in title.
  • When entering the abstract title online, use ALL caps and DO NOT put a period at the end of the title.
  • Enter the title in the “title” field only and do not enter the title in the body of the abstract.
  • Author names and affiliations should not appear in title.

This Is An Improperly Formatted Abstract Title.
this is an improperly formatted abstract title

Abstract Author Format

  • Submitting authors will be listed as the primary author on the abstract, NO EXCEPTIONS.
  • Do not list authors or commercial relationships in the body of the abstract. Please consult with your co-authors on how they would like their names to appear prior to the submission of the abstract.
  • All authors must disclose any relevant financial relationship(s) at the time of abstract submission. There is no limit on the number of authors that may be included in the author block.

Abstract Content Format

The abstract limit is 2,700 characters, including spaces. Count excludes the title, names of authors/coauthors, authors’ affiliations and disclosures. Abstracts marked “incomplete” at the close of the submission deadline will be ineligible for consideration.

Prior to submitting the abstract, please ensure that it is proofread by an individual who speaks fluent English and can make recommendations as needed.

  • Do not use new technical words, laboratory slang, words not defined in dictionaries, abbreviations, or terminology not consistent with internationally accepted guidelines. Define any abbreviations the first time they are used. Omit all names and geographical references in the body of the abstract. Organize content as follows:
    • Objective: Background or Statement of Purpose
    • Methods: Methods, materials and analytical procedure used
    • Results: Summary of the results in sufficient detail to support conclusion
    • Discussion: Discuss the content and interpret the data
    • Conclusion: Conclusions reached (do not state “results will be discussed”)
  • Use standard abbreviations. Place special or unusual abbreviations in parentheses after the first time the full word appears. Do not abbreviate compounds in the title of the abstract. Use numerals to indicate numbers, except when beginning sentences.
  • AACE will only publish commonly used acronyms. Please refrain from using all trial group acronyms in abstract titles. Acronyms may remain in the body of the abstract and in the author list.
  • A limit of only one table, image, or graph may be submitted online along with your abstract. Any additional tables, images or graphs may be included in the poster session.

Copyright Transfer Agreement

During submission, the author will be requested to agree to a copyright transfer if the abstract is accepted. The submitting author will agree to the terms of the copyright transfer on behalf of all co-authors. The Agreement transfers to AACE the copyright and all other rights of the material comprising the abstract upon acceptance. The American Association of Clinical Endocrinologists, as holder of the copyright on the accepted abstract, reserves all right of reproduction, distribution, performance, display, and the right to create derivative works in both print and digital formats. No patient rights are assigned.

Abstract Review

Abstracts will be reviewed by the AACE Abstract Review Subcommittee and scored numerically 1 through 10 based on merit and significance to the science and practice of endocrinology, as well as their creativity and uniqueness.

  • After the submission deadline, completed abstracts will be reviewed. “Incomplete” abstracts are considered incomplete and will not be reviewed. To ensure the integrity of the review process, revisions to abstracts will not be accepted after the submission deadline – no exceptions.
  • All abstracts will be reviewed without knowledge of the author(s), institution(s) or disclosure information.
  • Accepted abstracts will be selected for publication only, poster presentation, or oral presentation.
  • Top scoring abstracts will be eligible for prizes, and the most outstanding abstracts among them will be considered for oral presentation.
  • A complete list of prizes will be available on the AACE Annual Meeting website. Original research and clinical trials will receive higher consideration for awards.

Travel Grants

AACE members who are the primary author will be considered for travel grants.

  • 1 International Fellow-in-Training Travel Grant in the amount of $2,500
  • 5 International Non-Fellow physician Travel Grants for $2,000 each
  • 5 Domestic Fellow-in-Training Travel Grants for $1,000 each*
  • 3 Domestic Resident physician Travel Grants for internal medicine, pediatric, or surgical residents, includes a PAID two night hotel stay and flights *

*To qualify for the Domestic Travel Grants, the Fellow- in-Training or Resident must be an AACE Member enrolled in a fellowship program or residency within the United States.

Abstract Notifications

The primary authors were notified of the status of their abstract in early February. It is the primary author’s responsibility to then notify all co-authors. AACE requests that all interested parties please refrain from directly contacting the AACE offices to obtain information regarding abstract status, notification distribution and/or publication dates.
The submitting/primary author is the only author who received notification from AACE.


After December 6, 2017, presenting authors may submit a request to have an abstract withdrawn. All requests can only be made by the presenting author and must be submitted via e-mail to

Withdrawal requests must be received by Friday, March 2, 2018 and include the following:

  • Abstract ID Number
  • Abstract Title
  • Presenting Author’s Name
  • The removal of the abstract from printed materials cannot be guaranteed if the request is received after March 2, 2018.

Late-Breaking Abstracts - CLOSED

The late-breaking abstract category allows for the submission of truly late-breaking scientific research for which no preliminary data are available at the time of the Friday, March 23, 2018 abstract submission deadline.

Late-breaking abstracts should present data that is ground-breaking, innovative and has a high impact factor. This category is not a mechanism to allow for updated data to be submitted later when preliminary data are available by the general abstract submission deadline.


Late-breaking Abstracts will be published online before the annual meeting.

Poster Schedule

Important Dates


Wednesday, December 6, 2017 at 11:59 pm ET
Abstract submission site closes at 11:59 pm ET (No exceptions) You will not be able to access your submission after 11:59 pm Eastern Time on Wednesday, December 6, 2017. There is no limit for the number of abstracts that can be submitted; however, someone must be in attendance to present each accepted poster.

mid-February, 2018
Presenting Author Notification

February 13, 2018
Late-breaking abstract submission site opens

March 23, 2018 at 11:59 pm ET
Late-breaking abstract submission site closes at 11:59 pm ET









2017 THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS | All pen and ink drawings created by AACE staff member Alex Valladares